# Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation

> **NCT03292445** · EARLY_PHASE1 · UNKNOWN · sponsor: **Samuel Strober** · enrollment: 24 (estimated)

## Conditions studied

- Immune Tolerance

## Interventions

- **PROCEDURE:** Immune tolerance after kidney transplant
- **DRUG:** Donor blood stem cells and T cells

## Key facts

- **NCT ID:** NCT03292445
- **Lead sponsor:** Samuel Strober
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-14
- **Primary completion:** 2022-02-14
- **Final completion:** 2024-02-14
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2020-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03292445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03292445, "Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03292445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*